
Michael Lim, MD, director of Brain Tumor Immunotherapy, associate professor of Neurosurgery, Johns Hopkins Medicine, discusses checkpoint inhibitors in glioblastoma.

Your AI-Trained Oncology Knowledge Connection!


Published: February 9th 2016 | Updated: